Status:
COMPLETED
Propofol vs Sevoflurane in Cyanotic Congenital Heart Disease
Lead Sponsor:
Cukurova University
Conditions:
Cyanotic Congenital Heart Disease
Pediatric HD
Eligibility:
All Genders
1-10 years
Phase:
PHASE4
Brief Summary
The stress response to surgery compromises a series of humoral, metabolic, or cellular reactions. Cardiac surgery with use of cardiopulmonary bypass (CPB) is a major activator of the systemic inflamma...
Detailed Description
The stress response to surgery compromises a series of humoral, metabolic, or cellular reactions. Cardiac surgery with use of cardiopulmonary bypass (CPB) is a major activator of the systemic inflamma...
Eligibility Criteria
Inclusion
- 1-10 years old
- Patients with cyanotic congenital heart disease undergoing open heart surgery with CPB
Exclusion
- Patients with liver or renal dysfunction
- Patients with inflammatory disease
- Patients with hemostatic disorders
- Preoperative use of anti-inflammatory and/or antioxidant drugs
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04125550
Start Date
January 1 2020
End Date
January 1 2022
Last Update
April 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cukurova University
Adana, Turkey (Türkiye), 01330